R. C. Milán-Segovia

Clinical Pharmacokinetics of Rifampin in Patients with Tuberculosis and Type 2 Diabetes Mellitus: Association with Biochemical and Immunological Parameters

Susanna Edith Medellín‐Garibay, Nancy Cortez-Espinosa, R. C. Milán-Segovia et al. · Antimicrobial Agents and Chemotherapy · 2015 · 36 citations · Full text

Medicine, Clinical Pharmacokinetics, Immunology +7

Relative bioavailability of rifampicin in a three-drug fixed-dose combination formulation.

R. C. Milán-Segovia, Adriana Miriam Domínguez‐Ramírez, Helgi Jung‐Cook et al. · PubMed · 2010 · 30 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population

Raúl A. Salazar‐González, Rocío Gómez, Silvia Romano‐Moreno et al. · Molecular Biology Reports · 2014 · 20 citations

Life Sciences, Genetics, Immunology +10

Population pharmacokinetics of levetiracetam in neonates with seizures

Victoria Lima‐Rogel, Edgar López-López, Susanna Edith Medellín‐Garibay et al. · Journal of Clinical Pharmacy and Therapeutics · 2017 · 20 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Expression and genotype-dependent catalytic activity of N-acetyltransferase 2 (NAT2) in human peripheral blood mononuclear cells and its modulation by Sirtuin 1

Raúl A. Salazar‐González, Eneida Turiján-Espinoza, David W. Hein et al. · Biochemical Pharmacology · 2018 · 18 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12